Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Injected insulin

Peptide · Agonist of insulin receptor (INSR)

Phase 3 Most advanced trial (none active)
1 Registered trials

What is Injected insulin?

Injected insulin is a peptide hormone given by injection before meals, dosed to each patient. It is studied in diabetes mellitus, asthma and chronic obstructive pulmonary disease.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Peptide
Targets
insulin receptor (INSR)
Mechanism
Agonist of insulin receptor (INSR)
Therapy area
Endocrine, Respiratory
In trials of
ALKS
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00157339 Phase 3 Diabetes Mellitus Completed ALKS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

AsthmaDiabetes MellitusPulmonary Disease, Chronic Obstructive

Other drugs acting on INSR

Insulin Degludec FDA approved Insulin Glargine FDA approved Insulin Lispro FDA approved Injectable insulin Phase 3 ORMD-0801 Phase 3

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.